nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—HTR2A—Alzheimer's disease	0.331	1	CbGaD
Methylergometrine—HTR2A—Donepezil—Alzheimer's disease	0.237	0.62	CbGbCtD
Methylergometrine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0627	0.164	CbGbCtD
Methylergometrine—CYP3A4—Donepezil—Alzheimer's disease	0.0501	0.131	CbGbCtD
Methylergometrine—CYP3A4—Galantamine—Alzheimer's disease	0.0323	0.0845	CbGbCtD
Methylergometrine—HTR2C—choroid plexus—Alzheimer's disease	0.0184	0.19	CbGeAlD
Methylergometrine—HTR2A—choroid plexus—Alzheimer's disease	0.00922	0.0954	CbGeAlD
Methylergometrine—DRD1—telencephalic ventricle—Alzheimer's disease	0.00693	0.0717	CbGeAlD
Methylergometrine—HTR2A—locus ceruleus—Alzheimer's disease	0.0057	0.0589	CbGeAlD
Methylergometrine—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00539	0.0557	CbGeAlD
Methylergometrine—HTR2A—cerebellar cortex—Alzheimer's disease	0.00464	0.048	CbGeAlD
Methylergometrine—HTR1F—forebrain—Alzheimer's disease	0.00358	0.037	CbGeAlD
Methylergometrine—HTR1F—telencephalon—Alzheimer's disease	0.00329	0.034	CbGeAlD
Methylergometrine—HTR1E—forebrain—Alzheimer's disease	0.0031	0.0321	CbGeAlD
Methylergometrine—Atrioventricular block—Galantamine—Alzheimer's disease	0.00287	0.0269	CcSEcCtD
Methylergometrine—HTR1E—telencephalon—Alzheimer's disease	0.00285	0.0295	CbGeAlD
Methylergometrine—Ventricular tachycardia—Galantamine—Alzheimer's disease	0.00278	0.0261	CcSEcCtD
Methylergometrine—HTR2A—telencephalic ventricle—Alzheimer's disease	0.0027	0.0279	CbGeAlD
Methylergometrine—Cramps of lower extremities—Galantamine—Alzheimer's disease	0.00255	0.024	CcSEcCtD
Methylergometrine—Atrioventricular block—Donepezil—Alzheimer's disease	0.00222	0.0208	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Galantamine—Alzheimer's disease	0.00206	0.0193	CcSEcCtD
Methylergometrine—Atrioventricular block—Memantine—Alzheimer's disease	0.00202	0.0189	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Donepezil—Alzheimer's disease	0.00198	0.0186	CcSEcCtD
Methylergometrine—Atrioventricular block—Rivastigmine—Alzheimer's disease	0.00197	0.0185	CcSEcCtD
Methylergometrine—HTR1F—nervous system—Alzheimer's disease	0.00194	0.0201	CbGeAlD
Methylergometrine—HTR1F—central nervous system—Alzheimer's disease	0.00187	0.0194	CbGeAlD
Methylergometrine—DRD1—forebrain—Alzheimer's disease	0.00181	0.0187	CbGeAlD
Methylergometrine—Cramps of lower extremities—Rivastigmine—Alzheimer's disease	0.00176	0.0165	CcSEcCtD
Methylergometrine—HTR1E—nervous system—Alzheimer's disease	0.00168	0.0174	CbGeAlD
Methylergometrine—DRD1—telencephalon—Alzheimer's disease	0.00166	0.0172	CbGeAlD
Methylergometrine—Thrombophlebitis—Memantine—Alzheimer's disease	0.00164	0.0154	CcSEcCtD
Methylergometrine—HTR1E—central nervous system—Alzheimer's disease	0.00162	0.0168	CbGeAlD
Methylergometrine—Thrombophlebitis—Rivastigmine—Alzheimer's disease	0.00161	0.015	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Donepezil—Alzheimer's disease	0.0016	0.015	CcSEcCtD
Methylergometrine—HTR1F—brain—Alzheimer's disease	0.00149	0.0154	CbGeAlD
Methylergometrine—Haematuria—Galantamine—Alzheimer's disease	0.00148	0.0139	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Memantine—Alzheimer's disease	0.00145	0.0136	CcSEcCtD
Methylergometrine—Bradycardia—Galantamine—Alzheimer's disease	0.00142	0.0133	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Rivastigmine—Alzheimer's disease	0.00142	0.0133	CcSEcCtD
Methylergometrine—Methysergide—HTR6—Alzheimer's disease	0.00141	0.289	CrCbGaD
Methylergometrine—HTR2C—forebrain—Alzheimer's disease	0.00141	0.0145	CbGeAlD
Methylergometrine—Hallucination—Galantamine—Alzheimer's disease	0.00139	0.013	CcSEcCtD
Methylergometrine—HTR2A—blood vessel—Alzheimer's disease	0.00134	0.0138	CbGeAlD
Methylergometrine—HTR2B—forebrain—Alzheimer's disease	0.00132	0.0137	CbGeAlD
Methylergometrine—Sweating increased—Donepezil—Alzheimer's disease	0.00132	0.0123	CcSEcCtD
Methylergometrine—Angina pectoris—Donepezil—Alzheimer's disease	0.00132	0.0123	CcSEcCtD
Methylergometrine—Tinnitus—Galantamine—Alzheimer's disease	0.0013	0.0122	CcSEcCtD
Methylergometrine—Cardiac disorder—Galantamine—Alzheimer's disease	0.0013	0.0122	CcSEcCtD
Methylergometrine—HTR2C—telencephalon—Alzheimer's disease	0.00129	0.0134	CbGeAlD
Methylergometrine—HTR1E—brain—Alzheimer's disease	0.00129	0.0133	CbGeAlD
Methylergometrine—HTR2B—telencephalon—Alzheimer's disease	0.00121	0.0126	CbGeAlD
Methylergometrine—Angina pectoris—Memantine—Alzheimer's disease	0.0012	0.0112	CcSEcCtD
Methylergometrine—Sweating increased—Memantine—Alzheimer's disease	0.0012	0.0112	CcSEcCtD
Methylergometrine—Sweating increased—Rivastigmine—Alzheimer's disease	0.00117	0.011	CcSEcCtD
Methylergometrine—Angina pectoris—Rivastigmine—Alzheimer's disease	0.00117	0.011	CcSEcCtD
Methylergometrine—Muscle spasms—Galantamine—Alzheimer's disease	0.00117	0.011	CcSEcCtD
Methylergometrine—Haematuria—Donepezil—Alzheimer's disease	0.00115	0.0108	CcSEcCtD
Methylergometrine—Bradycardia—Donepezil—Alzheimer's disease	0.0011	0.0103	CcSEcCtD
Methylergometrine—Hallucination—Donepezil—Alzheimer's disease	0.00108	0.0101	CcSEcCtD
Methylergometrine—Palpitations—Galantamine—Alzheimer's disease	0.00107	0.0101	CcSEcCtD
Methylergometrine—Convulsion—Galantamine—Alzheimer's disease	0.00105	0.00987	CcSEcCtD
Methylergometrine—Bromocriptine—HTR6—Alzheimer's disease	0.00105	0.215	CrCbGaD
Methylergometrine—Hypertension—Galantamine—Alzheimer's disease	0.00105	0.00984	CcSEcCtD
Methylergometrine—Haematuria—Memantine—Alzheimer's disease	0.00104	0.00979	CcSEcCtD
Methylergometrine—Chest pain—Galantamine—Alzheimer's disease	0.00103	0.0097	CcSEcCtD
Methylergometrine—Haematuria—Rivastigmine—Alzheimer's disease	0.00102	0.00957	CcSEcCtD
Methylergometrine—Tinnitus—Donepezil—Alzheimer's disease	0.00101	0.00946	CcSEcCtD
Methylergometrine—Bradycardia—Memantine—Alzheimer's disease	0.001	0.00938	CcSEcCtD
Methylergometrine—DRD1—nervous system—Alzheimer's disease	0.000983	0.0102	CbGeAlD
Methylergometrine—Bradycardia—Rivastigmine—Alzheimer's disease	0.000979	0.00918	CcSEcCtD
Methylergometrine—Hallucination—Memantine—Alzheimer's disease	0.000978	0.00917	CcSEcCtD
Methylergometrine—Nervous system disorder—Galantamine—Alzheimer's disease	0.000973	0.00912	CcSEcCtD
Methylergometrine—Tachycardia—Galantamine—Alzheimer's disease	0.000968	0.00908	CcSEcCtD
Methylergometrine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000959	0.00899	CcSEcCtD
Methylergometrine—Hallucination—Rivastigmine—Alzheimer's disease	0.000956	0.00897	CcSEcCtD
Methylergometrine—DRD1—central nervous system—Alzheimer's disease	0.000946	0.00978	CbGeAlD
Methylergometrine—Hypotension—Galantamine—Alzheimer's disease	0.000927	0.00869	CcSEcCtD
Methylergometrine—Tinnitus—Memantine—Alzheimer's disease	0.000916	0.00859	CcSEcCtD
Methylergometrine—Cardiac disorder—Memantine—Alzheimer's disease	0.000912	0.00855	CcSEcCtD
Methylergometrine—Muscle spasms—Donepezil—Alzheimer's disease	0.000906	0.00849	CcSEcCtD
Methylergometrine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000896	0.0084	CcSEcCtD
Methylergometrine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000892	0.00836	CcSEcCtD
Methylergometrine—Paraesthesia—Galantamine—Alzheimer's disease	0.000891	0.00835	CcSEcCtD
Methylergometrine—Convulsion—Donepezil—Alzheimer's disease	0.000816	0.00765	CcSEcCtD
Methylergometrine—Hypertension—Donepezil—Alzheimer's disease	0.000813	0.00763	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000811	0.00761	CcSEcCtD
Methylergometrine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000805	0.00754	CcSEcCtD
Methylergometrine—Chest pain—Donepezil—Alzheimer's disease	0.000802	0.00752	CcSEcCtD
Methylergometrine—HTR2A—embryo—Alzheimer's disease	0.000798	0.00825	CbGeAlD
Methylergometrine—Abdominal pain—Galantamine—Alzheimer's disease	0.000784	0.00735	CcSEcCtD
Methylergometrine—HTR2C—nervous system—Alzheimer's disease	0.000764	0.0079	CbGeAlD
Methylergometrine—Palpitations—Memantine—Alzheimer's disease	0.000756	0.00709	CcSEcCtD
Methylergometrine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000754	0.00707	CcSEcCtD
Methylergometrine—DRD1—brain—Alzheimer's disease	0.000751	0.00777	CbGeAlD
Methylergometrine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000743	0.00697	CcSEcCtD
Methylergometrine—Convulsion—Memantine—Alzheimer's disease	0.000741	0.00695	CcSEcCtD
Methylergometrine—Palpitations—Rivastigmine—Alzheimer's disease	0.000739	0.00693	CcSEcCtD
Methylergometrine—Hypertension—Memantine—Alzheimer's disease	0.000738	0.00692	CcSEcCtD
Methylergometrine—HTR2C—central nervous system—Alzheimer's disease	0.000735	0.0076	CbGeAlD
Methylergometrine—Chest pain—Memantine—Alzheimer's disease	0.000728	0.00683	CcSEcCtD
Methylergometrine—Convulsion—Rivastigmine—Alzheimer's disease	0.000725	0.0068	CcSEcCtD
Methylergometrine—Hypertension—Rivastigmine—Alzheimer's disease	0.000722	0.00677	CcSEcCtD
Methylergometrine—Hypotension—Donepezil—Alzheimer's disease	0.000718	0.00674	CcSEcCtD
Methylergometrine—HTR2B—nervous system—Alzheimer's disease	0.000717	0.00742	CbGeAlD
Methylergometrine—Chest pain—Rivastigmine—Alzheimer's disease	0.000712	0.00668	CcSEcCtD
Methylergometrine—HTR2A—forebrain—Alzheimer's disease	0.000706	0.0073	CbGeAlD
Methylergometrine—HTR2B—central nervous system—Alzheimer's disease	0.000691	0.00714	CbGeAlD
Methylergometrine—Paraesthesia—Donepezil—Alzheimer's disease	0.00069	0.00647	CcSEcCtD
Methylergometrine—Dyspnoea—Donepezil—Alzheimer's disease	0.000685	0.00643	CcSEcCtD
Methylergometrine—Nervous system disorder—Memantine—Alzheimer's disease	0.000685	0.00642	CcSEcCtD
Methylergometrine—Tachycardia—Memantine—Alzheimer's disease	0.000681	0.00639	CcSEcCtD
Methylergometrine—Diarrhoea—Galantamine—Alzheimer's disease	0.000679	0.00636	CcSEcCtD
Methylergometrine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000675	0.00633	CcSEcCtD
Methylergometrine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00067	0.00628	CcSEcCtD
Methylergometrine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000667	0.00625	CcSEcCtD
Methylergometrine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00066	0.00619	CcSEcCtD
Methylergometrine—Dizziness—Galantamine—Alzheimer's disease	0.000656	0.00615	CcSEcCtD
Methylergometrine—Hypotension—Memantine—Alzheimer's disease	0.000652	0.00612	CcSEcCtD
Methylergometrine—HTR2A—telencephalon—Alzheimer's disease	0.000649	0.00671	CbGeAlD
Methylergometrine—Hypotension—Rivastigmine—Alzheimer's disease	0.000638	0.00598	CcSEcCtD
Methylergometrine—Vomiting—Galantamine—Alzheimer's disease	0.000631	0.00591	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000629	0.00589	CcSEcCtD
Methylergometrine—Paraesthesia—Memantine—Alzheimer's disease	0.000627	0.00588	CcSEcCtD
Methylergometrine—Rash—Galantamine—Alzheimer's disease	0.000626	0.00586	CcSEcCtD
Methylergometrine—Dermatitis—Galantamine—Alzheimer's disease	0.000625	0.00586	CcSEcCtD
Methylergometrine—Dyspnoea—Memantine—Alzheimer's disease	0.000622	0.00584	CcSEcCtD
Methylergometrine—Headache—Galantamine—Alzheimer's disease	0.000622	0.00583	CcSEcCtD
Methylergometrine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000613	0.00575	CcSEcCtD
Methylergometrine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000609	0.00571	CcSEcCtD
Methylergometrine—Abdominal pain—Donepezil—Alzheimer's disease	0.000608	0.0057	CcSEcCtD
Methylergometrine—Nausea—Galantamine—Alzheimer's disease	0.000589	0.00553	CcSEcCtD
Methylergometrine—HTR2C—brain—Alzheimer's disease	0.000584	0.00603	CbGeAlD
Methylergometrine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000571	0.00535	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000558	0.00524	CcSEcCtD
Methylergometrine—Abdominal pain—Memantine—Alzheimer's disease	0.000552	0.00517	CcSEcCtD
Methylergometrine—HTR2B—brain—Alzheimer's disease	0.000548	0.00567	CbGeAlD
Methylergometrine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00054	0.00506	CcSEcCtD
Methylergometrine—Diarrhoea—Donepezil—Alzheimer's disease	0.000526	0.00493	CcSEcCtD
Methylergometrine—Dizziness—Donepezil—Alzheimer's disease	0.000508	0.00477	CcSEcCtD
Methylergometrine—Vomiting—Donepezil—Alzheimer's disease	0.000489	0.00458	CcSEcCtD
Methylergometrine—Rash—Donepezil—Alzheimer's disease	0.000485	0.00455	CcSEcCtD
Methylergometrine—Dermatitis—Donepezil—Alzheimer's disease	0.000484	0.00454	CcSEcCtD
Methylergometrine—Headache—Donepezil—Alzheimer's disease	0.000482	0.00452	CcSEcCtD
Methylergometrine—Diarrhoea—Memantine—Alzheimer's disease	0.000478	0.00448	CcSEcCtD
Methylergometrine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000467	0.00438	CcSEcCtD
Methylergometrine—Dizziness—Memantine—Alzheimer's disease	0.000462	0.00433	CcSEcCtD
Methylergometrine—Nausea—Donepezil—Alzheimer's disease	0.000457	0.00428	CcSEcCtD
Methylergometrine—Dizziness—Rivastigmine—Alzheimer's disease	0.000452	0.00423	CcSEcCtD
Methylergometrine—Vomiting—Memantine—Alzheimer's disease	0.000444	0.00416	CcSEcCtD
Methylergometrine—Rash—Memantine—Alzheimer's disease	0.00044	0.00413	CcSEcCtD
Methylergometrine—Dermatitis—Memantine—Alzheimer's disease	0.00044	0.00412	CcSEcCtD
Methylergometrine—Headache—Memantine—Alzheimer's disease	0.000437	0.0041	CcSEcCtD
Methylergometrine—Vomiting—Rivastigmine—Alzheimer's disease	0.000434	0.00407	CcSEcCtD
Methylergometrine—Rash—Rivastigmine—Alzheimer's disease	0.000431	0.00404	CcSEcCtD
Methylergometrine—Dermatitis—Rivastigmine—Alzheimer's disease	0.00043	0.00403	CcSEcCtD
Methylergometrine—Headache—Rivastigmine—Alzheimer's disease	0.000428	0.00401	CcSEcCtD
Methylergometrine—Methysergide—HTR2A—Alzheimer's disease	0.000416	0.085	CrCbGaD
Methylergometrine—Nausea—Memantine—Alzheimer's disease	0.000415	0.00389	CcSEcCtD
Methylergometrine—Nausea—Rivastigmine—Alzheimer's disease	0.000406	0.0038	CcSEcCtD
Methylergometrine—Pergolide—HTR2A—Alzheimer's disease	0.000385	0.0788	CrCbGaD
Methylergometrine—HTR2A—nervous system—Alzheimer's disease	0.000383	0.00396	CbGeAlD
Methylergometrine—HTR2A—central nervous system—Alzheimer's disease	0.000369	0.00381	CbGeAlD
Methylergometrine—HTR2A—cerebellum—Alzheimer's disease	0.00036	0.00373	CbGeAlD
Methylergometrine—CYP3A4—nervous system—Alzheimer's disease	0.000355	0.00367	CbGeAlD
Methylergometrine—Pergolide—CYP2D6—Alzheimer's disease	0.000352	0.072	CrCbGaD
Methylergometrine—CYP3A4—central nervous system—Alzheimer's disease	0.000341	0.00353	CbGeAlD
Methylergometrine—Lisuride—HTR2A—Alzheimer's disease	0.000334	0.0683	CrCbGaD
Methylergometrine—Ergotamine—HTR2A—Alzheimer's disease	0.000321	0.0657	CrCbGaD
Methylergometrine—Bromocriptine—HTR2A—Alzheimer's disease	0.000309	0.0633	CrCbGaD
Methylergometrine—Lisuride—CYP2D6—Alzheimer's disease	0.000305	0.0625	CrCbGaD
Methylergometrine—HTR2A—brain—Alzheimer's disease	0.000293	0.00303	CbGeAlD
Methylergometrine—DRD1—Signaling Pathways—APP—Alzheimer's disease	1.84e-05	0.000233	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IAPP—Alzheimer's disease	1.84e-05	0.000232	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.8e-05	0.000228	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—A2M—Alzheimer's disease	1.8e-05	0.000228	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—ESR1—Alzheimer's disease	1.8e-05	0.000227	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.79e-05	0.000227	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CRH—Alzheimer's disease	1.78e-05	0.000226	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.78e-05	0.000225	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—F2—Alzheimer's disease	1.77e-05	0.000224	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—F2—Alzheimer's disease	1.77e-05	0.000223	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CCR5—Alzheimer's disease	1.76e-05	0.000223	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PSEN2—Alzheimer's disease	1.75e-05	0.000221	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—NOTCH1—Alzheimer's disease	1.74e-05	0.00022	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PLCB1—Alzheimer's disease	1.73e-05	0.000219	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—GSK3B—Alzheimer's disease	1.73e-05	0.000218	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—HTR2A—Alzheimer's disease	1.72e-05	0.000218	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NGFR—Alzheimer's disease	1.72e-05	0.000217	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CREB1—Alzheimer's disease	1.71e-05	0.000217	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.71e-05	0.000216	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—CREB1—Alzheimer's disease	1.71e-05	0.000216	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—INS—Alzheimer's disease	1.7e-05	0.000215	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NPS—Alzheimer's disease	1.69e-05	0.000214	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CCR5—Alzheimer's disease	1.68e-05	0.000213	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PPP3CA—Alzheimer's disease	1.68e-05	0.000213	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—ADAM10—Alzheimer's disease	1.68e-05	0.000212	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CCL2—Alzheimer's disease	1.68e-05	0.000212	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—CCL2—Alzheimer's disease	1.67e-05	0.000211	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—F2—Alzheimer's disease	1.66e-05	0.00021	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PTK2B—Alzheimer's disease	1.66e-05	0.00021	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IGF1—Alzheimer's disease	1.65e-05	0.000208	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.63e-05	0.000206	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—GSK3B—Alzheimer's disease	1.63e-05	0.000206	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NGFR—Alzheimer's disease	1.62e-05	0.000205	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CREB1—Alzheimer's disease	1.62e-05	0.000204	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NTRK2—Alzheimer's disease	1.61e-05	0.000204	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—GAB2—Alzheimer's disease	1.61e-05	0.000204	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—SST—Alzheimer's disease	1.61e-05	0.000204	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—PRKCG—Alzheimer's disease	1.61e-05	0.000204	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—CREB1—Alzheimer's disease	1.61e-05	0.000203	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CALM1—Alzheimer's disease	1.61e-05	0.000203	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—INS—Alzheimer's disease	1.61e-05	0.000203	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NPY—Alzheimer's disease	1.61e-05	0.000203	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—GSK3A—Alzheimer's disease	1.6e-05	0.000202	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IAPP—Alzheimer's disease	1.6e-05	0.000202	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—S100B—Alzheimer's disease	1.58e-05	0.0002	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CCL2—Alzheimer's disease	1.58e-05	0.0002	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—ADAM10—Alzheimer's disease	1.58e-05	0.0002	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—CCL2—Alzheimer's disease	1.57e-05	0.000199	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—APP—Alzheimer's disease	1.57e-05	0.000199	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.56e-05	0.000198	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IGF1—Alzheimer's disease	1.55e-05	0.000197	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CRH—Alzheimer's disease	1.55e-05	0.000196	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CCR5—Alzheimer's disease	1.53e-05	0.000193	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—F2—Alzheimer's disease	1.51e-05	0.000191	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IGF2—Alzheimer's disease	1.51e-05	0.000191	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.51e-05	0.00019	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—S100B—Alzheimer's disease	1.49e-05	0.000189	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—NOS3—Alzheimer's disease	1.49e-05	0.000189	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PLCB1—Alzheimer's disease	1.48e-05	0.000188	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NPS—Alzheimer's disease	1.47e-05	0.000186	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PPP3CA—Alzheimer's disease	1.46e-05	0.000185	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IGF1R—Alzheimer's disease	1.46e-05	0.000185	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.45e-05	0.000184	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—F2—Alzheimer's disease	1.44e-05	0.000183	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PTK2B—Alzheimer's disease	1.44e-05	0.000182	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IGF2—Alzheimer's disease	1.42e-05	0.00018	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—NOS3—Alzheimer's disease	1.41e-05	0.000178	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SST—Alzheimer's disease	1.4e-05	0.000177	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—GAB2—Alzheimer's disease	1.4e-05	0.000177	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NTRK2—Alzheimer's disease	1.4e-05	0.000177	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—LPL—Alzheimer's disease	1.4e-05	0.000177	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CALM1—Alzheimer's disease	1.4e-05	0.000177	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—GSK3A—Alzheimer's disease	1.39e-05	0.000176	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MEF2C—Alzheimer's disease	1.39e-05	0.000175	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NGFR—Alzheimer's disease	1.38e-05	0.000175	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IGF1R—Alzheimer's disease	1.38e-05	0.000174	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CREB1—Alzheimer's disease	1.38e-05	0.000174	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—APP—Alzheimer's disease	1.37e-05	0.000173	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PRKCG—Alzheimer's disease	1.36e-05	0.000172	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ADAM10—Alzheimer's disease	1.35e-05	0.000171	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CCL2—Alzheimer's disease	1.35e-05	0.00017	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NGF—Alzheimer's disease	1.32e-05	0.000168	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—LPL—Alzheimer's disease	1.32e-05	0.000167	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—F2—Alzheimer's disease	1.31e-05	0.000166	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MEF2C—Alzheimer's disease	1.31e-05	0.000165	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CCR5—Alzheimer's disease	1.29e-05	0.000163	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PLCB1—Alzheimer's disease	1.29e-05	0.000163	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PRKCG—Alzheimer's disease	1.28e-05	0.000162	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—AKT1—Alzheimer's disease	1.28e-05	0.000162	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—S100B—Alzheimer's disease	1.28e-05	0.000162	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CASP3—Alzheimer's disease	1.27e-05	0.00016	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—HTR2A—Alzheimer's disease	1.26e-05	0.00016	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—IL6—Alzheimer's disease	1.26e-05	0.000159	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NGF—Alzheimer's disease	1.25e-05	0.000158	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IGF2—Alzheimer's disease	1.22e-05	0.000154	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CCR5—Alzheimer's disease	1.22e-05	0.000154	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—AKT1—Alzheimer's disease	1.21e-05	0.000153	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NGFR—Alzheimer's disease	1.2e-05	0.000152	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CASP3—Alzheimer's disease	1.2e-05	0.000151	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CREB1—Alzheimer's disease	1.19e-05	0.000151	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—HTR2A—Alzheimer's disease	1.19e-05	0.00015	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—IL6—Alzheimer's disease	1.19e-05	0.00015	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IGF1R—Alzheimer's disease	1.18e-05	0.000149	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CALM1—Alzheimer's disease	1.18e-05	0.000149	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ADAM10—Alzheimer's disease	1.17e-05	0.000149	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—LEP—Alzheimer's disease	1.17e-05	0.000148	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—APOE—Alzheimer's disease	1.17e-05	0.000148	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CCL2—Alzheimer's disease	1.17e-05	0.000148	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MAPK8—Alzheimer's disease	1.17e-05	0.000147	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—AKT1—Alzheimer's disease	1.16e-05	0.000147	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CAV1—Alzheimer's disease	1.16e-05	0.000147	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—LPL—Alzheimer's disease	1.13e-05	0.000143	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—ESR1—Alzheimer's disease	1.12e-05	0.000142	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MEF2C—Alzheimer's disease	1.12e-05	0.000141	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—S100B—Alzheimer's disease	1.11e-05	0.00014	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CALM1—Alzheimer's disease	1.11e-05	0.00014	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—LEP—Alzheimer's disease	1.11e-05	0.00014	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—APOE—Alzheimer's disease	1.11e-05	0.00014	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—F2—Alzheimer's disease	1.11e-05	0.00014	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MAPK8—Alzheimer's disease	1.1e-05	0.000139	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PRKCG—Alzheimer's disease	1.1e-05	0.000139	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—AKT1—Alzheimer's disease	1.1e-05	0.000139	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CAV1—Alzheimer's disease	1.1e-05	0.000139	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NOTCH1—Alzheimer's disease	1.08e-05	0.000137	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—VEGFA—Alzheimer's disease	1.08e-05	0.000136	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NGF—Alzheimer's disease	1.07e-05	0.000135	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IGF2—Alzheimer's disease	1.06e-05	0.000134	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—ESR1—Alzheimer's disease	1.06e-05	0.000134	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—F2—Alzheimer's disease	1.04e-05	0.000132	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCR5—Alzheimer's disease	1.04e-05	0.000132	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IGF1R—Alzheimer's disease	1.02e-05	0.000129	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.02e-05	0.000129	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HTR2A—Alzheimer's disease	1.02e-05	0.000129	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—GSK3B—Alzheimer's disease	1.02e-05	0.000128	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—VEGFA—Alzheimer's disease	1.01e-05	0.000128	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CREB1—Alzheimer's disease	1.01e-05	0.000127	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—INS—Alzheimer's disease	1e-05	0.000127	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TGFB1—Alzheimer's disease	9.88e-06	0.000125	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CCL2—Alzheimer's disease	9.86e-06	0.000125	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—LPL—Alzheimer's disease	9.8e-06	0.000124	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MEF2C—Alzheimer's disease	9.71e-06	0.000123	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IGF1—Alzheimer's disease	9.69e-06	0.000123	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—GSK3B—Alzheimer's disease	9.58e-06	0.000121	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PRKCG—Alzheimer's disease	9.53e-06	0.000121	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CREB1—Alzheimer's disease	9.5e-06	0.00012	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CALM1—Alzheimer's disease	9.49e-06	0.00012	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—APOE—Alzheimer's disease	9.46e-06	0.00012	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—LEP—Alzheimer's disease	9.46e-06	0.00012	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—INS—Alzheimer's disease	9.45e-06	0.000119	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CAV1—Alzheimer's disease	9.37e-06	0.000119	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	9.37e-06	0.000119	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	9.37e-06	0.000119	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TGFB1—Alzheimer's disease	9.32e-06	0.000118	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CCL2—Alzheimer's disease	9.29e-06	0.000118	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NGF—Alzheimer's disease	9.28e-06	0.000117	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IGF1—Alzheimer's disease	9.14e-06	0.000116	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ESR1—Alzheimer's disease	9.03e-06	0.000114	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCR5—Alzheimer's disease	9.03e-06	0.000114	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	8.98e-06	0.000114	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—F2—Alzheimer's disease	8.92e-06	0.000113	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NOS3—Alzheimer's disease	8.78e-06	0.000111	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NOTCH1—Alzheimer's disease	8.73e-06	0.00011	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	8.65e-06	0.000109	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—A2M—Alzheimer's disease	8.35e-06	0.000106	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NOS3—Alzheimer's disease	8.28e-06	0.000105	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CALM1—Alzheimer's disease	8.24e-06	0.000104	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—LEP—Alzheimer's disease	8.21e-06	0.000104	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—APOE—Alzheimer's disease	8.21e-06	0.000104	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—GSK3B—Alzheimer's disease	8.19e-06	0.000104	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CAV1—Alzheimer's disease	8.14e-06	0.000103	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TP53—Alzheimer's disease	8.13e-06	0.000103	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CREB1—Alzheimer's disease	8.13e-06	0.000103	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—INS—Alzheimer's disease	8.08e-06	0.000102	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCL2—Alzheimer's disease	7.95e-06	0.000101	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ESR1—Alzheimer's disease	7.84e-06	9.92e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IGF1—Alzheimer's disease	7.82e-06	9.89e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—F2—Alzheimer's disease	7.75e-06	9.8e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TP53—Alzheimer's disease	7.67e-06	9.7e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	7.58e-06	9.59e-05	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—AKT1—Alzheimer's disease	7.53e-06	9.52e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CASP3—Alzheimer's disease	7.46e-06	9.43e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IL6—Alzheimer's disease	7.44e-06	9.41e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—IL6—Alzheimer's disease	7.41e-06	9.37e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	7.27e-06	9.19e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	7.18e-06	9.08e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	7.11e-06	9e-05	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	7.1e-06	8.98e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	7.09e-06	8.96e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	7.06e-06	8.93e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CASP3—Alzheimer's disease	7.03e-06	8.9e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IL6—Alzheimer's disease	7.02e-06	8.88e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—INS—Alzheimer's disease	7.02e-06	8.88e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—IL6—Alzheimer's disease	6.99e-06	8.84e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	6.9e-06	8.73e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—AKT1—Alzheimer's disease	6.87e-06	8.68e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MAPK8—Alzheimer's disease	6.85e-06	8.67e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—AKT1—Alzheimer's disease	6.84e-06	8.65e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	6.81e-06	8.61e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	6.81e-06	8.61e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	6.79e-06	8.59e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	6.68e-06	8.45e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—AKT1—Alzheimer's disease	6.48e-06	8.19e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MAPK8—Alzheimer's disease	6.46e-06	8.18e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—AKT1—Alzheimer's disease	6.45e-06	8.15e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	6.33e-06	8.01e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—VEGFA—Alzheimer's disease	6.33e-06	8.01e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	6.15e-06	7.78e-05	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	6.07e-06	7.68e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	6.02e-06	7.61e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	5.98e-06	7.56e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	5.97e-06	7.55e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	5.97e-06	7.55e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TGFB1—Alzheimer's disease	5.81e-06	7.35e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	5.79e-06	7.32e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	5.53e-06	7e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	5.51e-06	6.98e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	5.48e-06	6.93e-05	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	5.27e-06	6.67e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	5.22e-06	6.61e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	5.19e-06	6.57e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	5.11e-06	6.46e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	4.99e-06	6.31e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	4.97e-06	6.28e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	4.8e-06	6.07e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	4.79e-06	6.06e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TP53—Alzheimer's disease	4.78e-06	6.05e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	4.69e-06	5.93e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—LPL—Alzheimer's disease	4.54e-06	5.75e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TP53—Alzheimer's disease	4.51e-06	5.7e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	4.43e-06	5.61e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL6—Alzheimer's disease	4.38e-06	5.54e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL6—Alzheimer's disease	4.13e-06	5.22e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	4.09e-06	5.17e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	4.07e-06	5.15e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—AKT1—Alzheimer's disease	4.04e-06	5.11e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	3.86e-06	4.88e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	3.82e-06	4.83e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	3.81e-06	4.82e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—APOE—Alzheimer's disease	3.81e-06	4.82e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	3.77e-06	4.77e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	3.53e-06	4.47e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	3.35e-06	4.24e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	3.32e-06	4.2e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	3.26e-06	4.12e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—INS—Alzheimer's disease	3.25e-06	4.11e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	3.07e-06	3.88e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.85e-06	3.61e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	2.83e-06	3.58e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.61e-06	3.3e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.31e-06	1.66e-05	CbGpPWpGaD
